RxDoctor Payments Data

Godfrey Parkerson, MD

Vascular Surgery · New Orleans, LANPI 1245659549

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,277 of the $16,922 with a category attached, or 66.6%. 30 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 31.2% of the total.

$16,922in general payments, 2019–2025

Across 235 payments — averaging $72.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$5K
  • Medtronic$3K
  • Cook Medical LLC$2K
  • Silk Road Medical, Inc.$1K
  • Stryker$813
  • Centinel Spine, LLC$787
  • plus $4K from 24 others

What the payments were for

  • Travel & lodging$5,64433%
  • Food & beverage$11,27767%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,922 in reported general payments places this provider in the 75th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$68,387
Medicare patients
191
Services billed
441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$11,440
Cilostazol23$320
ClopidogrelClopidogrel Bisulfate35$286
Atorvastatin Calcium14$131
Alprazolam19$16
Meloxicam15$16

Paid to pharmacies, not to this prescriber.

Other vascular surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →